Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/12/2009WO2009116074A3 Substituted benzimidazoles as cannabinoid modulator
11/12/2009WO2009115906A3 A process for the preparation of carvedilol involving halohydrin derivative
11/12/2009WO2009115874A3 Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation
11/12/2009WO2009115834A3 Hormone inhibition
11/12/2009WO2009114475A3 Compositions comprising human pcsk9 and apolipoprotein b sirna and methods of use
11/12/2009WO2009113962A3 Composition and method for producing composition
11/12/2009WO2009112226A8 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
11/12/2009WO2009111852A3 Solid lipid nanoparticles containing retinoids
11/12/2009WO2009111691A3 Combination therapy with c-met and egfr antagonists
11/12/2009WO2009111530A3 Use of lipoxins to counteract the impact of anesthetic on inflammatory resolution
11/12/2009WO2009111159A3 Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
11/12/2009WO2009109870A3 Moisturizing hand sanitizer
11/12/2009WO2009109531A3 Zn/trimethoprim combination therapy
11/12/2009WO2009108838A8 Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof
11/12/2009WO2009108828A3 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
11/12/2009WO2009108067A3 Fatty acid derivatives for use in the prevention and treatment of hsmi
11/12/2009WO2009105756A3 Protection of neural retina by reduction of rod metabolism
11/12/2009WO2009105755A3 Macrocyclic prodrug compounds useful as therapeutics
11/12/2009WO2009105691A3 Uses of pentamidine and related compounds
11/12/2009WO2009105513A8 Novel compounds and methods for therapy
11/12/2009WO2009105513A3 Novel compounds and methods for therapy
11/12/2009WO2009105234A3 Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein
11/12/2009WO2009104021A3 Novel polymorphs and processes for their preparation
11/12/2009WO2009103901A3 Pharmaceutical composition containing an n‑phenylpyrazole derivative and glycofurol, use for the preparation of a topical veterinary medicament for combating fleas
11/12/2009WO2009103754A3 Novel use of 3,3'-diindolylmethane
11/12/2009WO2009103057A3 Polyglycerol sebecate peritoneal adhesion prevention barrier
11/12/2009WO2009103035A3 Templated open flocs of anisotropic particles for enhanced pulmonary delivery
11/12/2009WO2009100278A3 Beverage comprising arginine
11/12/2009WO2009099672A3 Breaking immunological tolerance with a genetically encoded unnatural amino acid
11/12/2009WO2009098458A3 Difluorobiphenylamide derivatives for the treatment of ocular hypertension
11/12/2009WO2009098404A3 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
11/12/2009WO2009083532A3 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof
11/12/2009WO2009080745A3 Perhydroquinoxaline derivatives as analgesics
11/12/2009WO2009077500A3 Azolylmethyloxiranes, use thereof and agents containing the same
11/12/2009WO2009076983A3 Improved pharmaceutical composition containing non-ergoline dopamine agonist and method for the preparation thereof
11/12/2009WO2009076141A3 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
11/12/2009WO2009074351A3 Solid forms of tenofovir disoproxil
11/12/2009WO2009073940A3 Use of phthalimide derivatives in the treatment of diseases
11/12/2009WO2009073067A3 Compositions and methods for ameliorating hyperlipidemia
11/12/2009WO2009072007A3 Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
11/12/2009WO2009071691A3 Oxindole derivatives and the use thereof as a medication
11/12/2009WO2009071631A3 Dibenzoazepine and dibenzooxazepine trpa1 agonists
11/12/2009WO2009070311A3 Crystal forms of o-desmethylvenlafaxine fumarate
11/12/2009WO2009070241A3 Angiotensin ii receptor antagonists
11/12/2009WO2009069132A3 Novel reverse transcriptase inhibitors
11/12/2009WO2009069006A3 Foam containing benzoyl peroxide
11/12/2009WO2009067686A3 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
11/12/2009WO2009062059A3 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/12/2009WO2009058848A3 Methods and devices for testing germicide activity
11/12/2009WO2009047323A3 Isoxazole compound for the treatment of cancer
11/12/2009WO2009035430A8 Compositions and methods for bone formation and remodeling
11/12/2009WO2009018807A9 Oxazolidinones as factor xa inhibitors, methods for the production thereof, and use thereof in therapy
11/12/2009WO2009007991A3 A new process for preparation of atovaquone and novel intermediates thereof
11/12/2009WO2008152398A3 Formulations for inhalation
11/12/2009WO2008139261A9 Omega-3 lipid compound
11/12/2009WO2008133344A3 Piperidine derivative and use thereof
11/12/2009WO2008121860A9 Peripheral opioid receptor antagonists and uses thereof
11/12/2009WO2008003155A3 Methods to prepare penta-1,4-dien-3-ones and substituted cyclohexanones and derivatives with antitumoral and antiparasitic properties, the compounds and their uses
11/12/2009WO2007084435A8 Methods for treating hepatitis c
11/12/2009WO2003096987A9 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/12/2009US20090282496 Androgen Receptor Related Methods for Treating Bladder Cancer
11/12/2009US20090282495 Neurotrophic factor manf and uses thereof
11/12/2009US20090281336 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
11/12/2009US20090281310 Cinnamide compound
11/12/2009US20090281308 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/12/2009US20090281307 Benzoimidazole compounds
11/12/2009US20090281285 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer
11/12/2009US20090281197 Acetic Acid/Thymol Compositions and Their Use in the Treatment of Onychomycosis
11/12/2009US20090281196 1-adamantyl chalcones for the treatment of proliferative disorders
11/12/2009US20090281195 Novel cocrystallization
11/12/2009US20090281194 Combinations for treating HIV-associated pain
11/12/2009US20090281193 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil
11/12/2009US20090281192 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil
11/12/2009US20090281191 Use of organic compounds
11/12/2009US20090281189 Treprostinil formulation
11/12/2009US20090281188 treating common acne, comedones, polymorphous acne, nodulocystic acne, acne conglobata or secondary acne with adapalene; sunscreen agents; antiproliferative agents
11/12/2009US20090281187 Anti-allergic agent
11/12/2009US20090281186 Composition and Method for Reducing Stress
11/12/2009US20090281185 Crystalline leukotriene b4
11/12/2009US20090281184 Pharmaceutical for prevention and treatment of ophthalmic disease induced by in-crease in vasopermeability
11/12/2009US20090281183 L-carnitine calcium fumarate, preparation method and application for the same
11/12/2009US20090281182 Agent for amelioration of dysphagia, and pharmaceutical or food composition comprising the same
11/12/2009US20090281181 Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases
11/12/2009US20090281180 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester
11/12/2009US20090281179 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache associated pain
11/12/2009US20090281178 Compounds for Lysosomal Modulation and Methods of Use
11/12/2009US20090281177 Butylphthalide Intravenous Emulsion and Application Thereof
11/12/2009US20090281176 Process for the synthesis of ramelteon and its intermediates
11/12/2009US20090281175 Avermectin compounds and treatment of dermatological disorders in humans therewith
11/12/2009US20090281174 Senescence inhibitor
11/12/2009US20090281172 Bis(thio-hydrazide amide) salts for treatment of cancers
11/12/2009US20090281171 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
11/12/2009US20090281170 Polynucleotide therapy
11/12/2009US20090281169 Compositions and Their Uses Directed to IL-4R Alpha
11/12/2009US20090281168 Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/12/2009US20090281167 Compositions and methods related to mirna modulation of neovascularization or angiogenesis
11/12/2009US20090281166 Treatment of Cancer by Inhibition of HSP27
11/12/2009US20090281165 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/12/2009US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009US20090281163 Regulatory elements that mediate retinal cell-specific gene expression
1 ... 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 ... 7860